Abstract:N,N‐[(diethylamino)(thiocarbonyl)]‐substituted benzamidine ligands have been synthesized from the reaction of N,N‐[(diethylamino)(thiocarbonyl)]benzimidoyl chloride with functionalized amines such as 2‐aminophenol and 2‐picolylamine. The reaction of N,N‐[(diethylamino)(thiocarbonyl)]‐2‐hydroxyphenylbenzamidine (H2L1) with ruthenium(II) precursor [RuHCl(CO)(PPh3)3] afforded complex 1 of the type [Ru(L1)(CO)(PPh3)2] in which the ligand coordinated in tridentate ONS mode. The reaction of H2L1 with copper precursor [Cu(CH3COO)(PPh3)2] induced C═N bond cleavage of the ligand and afforded complex 3 of the type [Cu(1,1‐DT)(Cl)(PPh3)2] (1,1‐DT = 1,1‐diethylthiourea) in which the ligand coordinated in a monodentate fashion. The ligand N,N‐[(diethylamino)(thiocarbonyl)]‐2‐picolylbenzamidine (HL2) reacted with ruthenium(II) and copper(I) precursors to form complex 2 of the type [Ru(1,1‐DT)(Cl2)(CO)(PPh3)2] and complex 3, respectively, in which the ligand underwent C═N cleavage and coordinated in a monodentate fashion via C═S group. In complexes 1 and 2, the two triphenylphosphine co‐ligands coordinated in trans position whereas, in complex 3, the two triphenylphosphine co‐ligands coordinated in cis position. All the compounds were characterized using infrared, UV–visible, (1H, 13C, 31P) NMR, ESI‐MS and elemental analyses. The molecular structures of ligand H2L1 and complexes 1–3 were determined using X‐ray crystallography, which confirmed the coordination mode of the ligands with metals. The crystal structure of complexes 1 and 2 revealed a distorted octahedral geometry around the ruthenium ion and the structure of complex 3 indicated a tetrahedral geometry around the copper ion. With the X‐ray structures, density functional theory computations were carried out to determine the electronic structure of the compounds. The interactions of complexes 1–3 with calf thymus DNA and bovine serum albumin protein were investigated using UV–visible and fluorescence spectroscopic and viscometric methods. Catecholase‐ and phosphatase‐like activities promoted by complexes 1–3 under physiological conditions have been studied. In vitro anticancer activities have been demonstrated by MTT assay, acridine orange/ethidium bromide and diamidino‐2‐phenylindole staining against various cancerous cell lines.

Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities.

Dissymmetric Thiosemicarbazone Ligands Containing Substituted Aldehyde Arm and Their Ruthenium(Ii) Carbonyl Complexes with Pph3/Asph3 As Ancillary Ligands: Synthesis, Structural Characterization, Dna/Bsa Interaction and in Vitro Anticancer Activity

Synthesis, Structural Characteristics, DNA Binding Properties and Cytotoxicity Studies of a Series of Ru(III) Complexes

Antibacterial and ct-DNA binding studies of new synthesized ruthenium (III) hydroxamate complexes: Design, synthesis, DFT calculations and in-vitro study

Synthesis and characterization of novel Ru(III) complexes of 2‐aminopyrazine: Interaction with biomolecules, antineoplastic activity, and computational investigation

Mononuclear ruthenium(III) complexes containing chelating thiosemicarbazones: synthesis, characterization and catalytic property

Catechol Oxidase, Phosphatase-Like Activity, Dna/Bsa Binding Studies of Ru-Ii Complexes of S-Allyldithiocarbazate: Synthesis and Spectral Studies

Unprecedented Formation Of Organo-Ruthenium(Ii) Complexes Containing 2-Hydroxy-1-Naphthaldehyde S-Benzyldithiocarbazate: Synthesis, X-Ray Crystal Structure, Dft Study And Their Biological Activities In Vitro

Biological evaluation of ruthenium(II) complexes appended curcumin derivatives: Synthesis, spectral characterization, anti-oxidant and anti-cancer studies

Toward a New Avenue in Ruthenium-Sulphur Chemistry of Binuclear Μ -Sulphido Bridged ( Μ -S) 2 Complexes Having Ru 2 S 2 Core: Targeted Synthesis, Crystal Structure, Biomolecules Interaction and Their in Vitro Anticancer Activities

Dna/Protein Binding, Molecular Docking, And In Vitro Anticancer Activity Of Some Thioether-Dipyrrinato Complexes

Synthesis, Spectroscopic, Antioxidant, and Antibacterial Investigations

Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.

Syntheses, Characterization and Antitumor Activity of Three Mononuclear Ruthenium(II) Complexes

Ruthenium(II) chalconate complexes: Synthesis, characterization, catalytic, and biological studies

Dinuclear arene ruthenium(II) arylthiourea complexes: Synthesis, structure, cancer cell growth inhibition and apoptosis induction studies

Ruthenium, rhodium and iridium complexes containing diazafluorene derivative ligands: synthesis and biological studies

Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline

Synthesis, characterization and anticancer activity of dinuclear ruthenium(II) complexes linked by an alkyl chain

Solvent-Assisted Formation of Ruthenium(Ii)/Copper(I) Complexes Containing Thiourea Derivatives: Synthesis, Crystal Structure, Density Functional Theory, Enzyme Mimetics and in Vitro Biological Perspectives

Synthesis, Characterization, and DNA Binding Studies of Ruthenium(II) Complexes with 2-Pyridyl-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-6,11-dione